By Mike Stobbe

A month after federal officials recommended new versions of COVID-19 vaccines, 7% of U.S. adults and 2% of children have gotten a shot.

One expert called the rates “abysmal.”

The numbers, presented Thursday at a meeting held by the Centers for Disease Control and Prevention, come from a national survey of thousands of Americans, conducted two weeks ago.

The data also indicated that nearly 40% of adults said they probably or definitely will not get the shot. A similar percentage of parents said they did not plan to vaccinate their children.

In the late summer, government health officials made the nation's COVID-19 vaccination campaign more like the annual flu campaign.

Officials approved updated shots that have a single target, an omicron descendant named XBB.1.5. They replaced vaccines that targeted the original coronavirus strain and a much earlier omicron version. Last month, the CDC recommended the new shots for everyone 6 months and older.

The government also transitioned to a commercialized system that relied on the health-care industry — not the government — to handle the distribution of the shots. Many people who immediately went for shots said pharmacies or doctors didn't have them.

Americans have been urged to get different iterations of the vaccines for more than 2/12 years. This year, COVID-19 deaths and hospitalizations fell to lower levels than seen in the previous three years.

Cases remain low compared with the pandemic's early months. Even so, health officials say about 18,000 hospitalization and 1,200 deaths are still being reported each week.

One expert at the meeting, Dr. Camille Kotton of Harvard Medical School, called the numbers “abysmal” and said part of the problem may be patient confusion. She urged stepped-up public education efforts.

Dr. David Kimberlin, of the University of Alabama at Birmingham, also expressed dismay.

“The recommendations are not being heard," he said.

Share:
More In Science
Finally, the Last Breaths of Theranos
John Carreyrou, the Wall Street Journal investigative reporter who first exposed the fraud at blood-testing company Theranos, said the former CEO of the once high-flying start-up had a chance to minimize the pain years ago, but instead used what money the company had to hide the truth.
San Francisco Picks Two Start-Ups for Scooter Program, Snubbing Giants Bird and Lime
In its pick of two small start-ups over Bird, Lime, Uber, and Lyft, San Francisco sent a signal that the most valuable mobility companies' "launch first, ask questions later" approach is catching up to them. Scoot Global and Skip were chosen because they said they would keep riders off the sidewalks and would provide services to low-income residents. Meanwhile, Santa Monica announced that it would open its shared mobility pilot program to e-scooters from Uber, Lyft, Bird, and Lime.
The State of Crypto After Latest SEC Rejection
Paul Johnson, partner at Harbor Peak, said regulators are nervous about being interpreted as backing crypto investing. But Bitcoin and Ethereum continue to benefit from widespread user adoption, while other platforms will likely fade away.
Load More